“Reducing risk; prevention, early diagnosis and innovative treatments”.
Save the date:
6th – 7th of March 2020
at The Assembly Rooms, Edinburgh UK
Registration Suspended Pending Further Communication
The GOCF Mission statement
The Global Oral Cancer Forum is an international assembly of passionate professionals focussed on building awareness of gaps in prevention, patient care, technology and services across the oral cancer continuum by facilitating partnerships that transcend cultural and economic diversity.
The GOCF Vision Statement
By building these partnerships, The Forum will promote the changes required for a substantial impact on incidence, morbidity and mortality of oral cancer worldwide.
The GOCF’20 Forum Will Focus the Conversation On:
9 of every 10 cases of mouth cancer are preventable – how do we improve preventive strategies?
For the population, for the individual patient and for each tumour subtype.
To get widespread engagement with our core messages and actionable outputs.
The only proven intervention that improves survival yet, most cases present at late stage.
Has massive potential in cancer; what data sets do we need, in what format and owned by whom.
Get your ideas seen by the world’s oral cancer thought leaders
The organising committee of GOCF20 invites poster submissions of original work under the theme of “Reducing risk; prevention, early diagnosis and innovative treatments”. Get your work seen by thought leaders in the field of Oral Cancer from across the world at GOCF’20 in Edinburgh.
Victor Lopes PhD, FRCS (Chair and Executive Director)
Trustee of the charity “Let’s Talk About Cancer” Edinburgh, U.K.
Niall McGoldrick BDS MFDS
Convenor of the charity “Let’s Talk About Cancer” / Specialty Registrar, Dental Public Health, NHS Fife, Scotland. U.K.
A. Ross Kerr, DDS, MSD
Clinical Professor, New York University College of Dentistry, USA
Saman Warnakulasuriya OBE, FDS, PhD, DSc
Emeritus Professor, Kings College London, UK
Jatin Shah MD FACS
Elliott W Strong Chair in head and neck oncology
Memorial Sloan Kettering Cancer Center, USA
Shannon Nanne RDH
Dental Hygienist, USA
Miriam Rosin PhD
British Columbia Oral Cancer Prevention Program
BC Cancer Agency
J. Silvio Gutkind PhD
Professor, Department of Pharmacology
Associate Director of Basic Science, UC San Diego Moores
Cancer Center, USA
Theme: “Reducing Risk: Prevention, Early Diagnosis & Innovative Treatments”
|8:15am-8:45am||Registration & Coffee|
|8:45am-8:50am||Welcome and Introduction:
Victor Lopes, Let’s Talk About Mouth Cancer, UK
Catherine Calderwood, Chief Medical Officer, Scottish Government
|8:55am-9:00am||Special Guest Welcome:
Prof Sir David Mason.
|9:00am-9:10am||Presentation of GOCF Leadership Award
Awardee: To be announced at the meeting
|9:10am-9:30am||Keynote 1: WHO
Benoit Varenne, Dental Officer, World Health Org
|9:30am-10:30am||Session 1: Risk Assessment in Primary Care: Who and How?
Chair: Saman Warnakulasuriya (King’s College London & WHO CC, UK)
|11:30am-11:15am||Coffee Break/Poster Viewing|
|11:15am-12:15pm||Session 2: Risk Stratification in Secondary Care: Triage and Surveillance
Chair: Ross Kerr (New York University, USA)
|12:15am-1:15pm||Session 3: Biomarkers for Prediction and Prognosis
Chair: Philip Sloan (Newcastle, U.K.)
Industry Sponsored Lecture: Immunobiology and Immunomodulators TBC
|2:15pm-3:15pm||Session 4: Risk Reduction for the Individual Patient
Chair: Victor Lopes (Let’s Talk About Mouth Cancer, UK)
|3:15pm-5:30pm||Global Café for Actionable Targets
Chair: Niall McGoldrick (Let’s Talk About Mouth Cancer, UK)
|6.00pm-8.00pm||Reception, Social Event & Networking|
|8:15am-9.00am||Industry sponsored Breakfast Symposium- HT Bioimaging, Israel. (www.htbioimaging.com)|
|9:00am-10:00am||Session 5: Risk and Management of Complications of Cancer Therapy
Chair: Jatin Shah (Memorial Sloan Kettering Cancer Center, USA)
|10:00am-10.30am||Keynote 2: Anil D’cruz (President-Elect, International Union Against Cancer, Switzerland)
|10:30am-11.15am||Coffee Break/Poster Viewing|
|11:15am-12:15pm||Session 6: Frontiers of Chemoprevention, Targeted Therapy, Immunotherapy
Chair: Silvio Gutkind (Moore’s Cancer Center, USA)
|12:15pm-1:30pm||Session 7: Reducing Population Risk & Inequalities
Chair: Newell Johnson (Griffith University, Australia)
|2:15pm-4:45pm||Big Data, Artificial Intelligence, Precision Medicine…Building a Bridge to the Future: Open Global Forum
Chair: Miriam Rosin (British Columbia Cancer Agency, Canada)
|4.45pm-5.30pm||Present Awards and Open Session:
“What are the actionable targets of GOCF20??”
Sign Up to Stay in Informed
If you subscribe to our email list we’ll send through periodic updates on our progress with the GOCF’20 Conference.
We will not use your email address for anything else and you can unsubscribe at any time.